Status:
COMPLETED
Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted Thyroidectomy
Lead Sponsor:
Yonsei University
Conditions:
Thyroid Cancer
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
Systemic lidocaine infusion may improve the patients' recovery quality and chronic post surgical pain after robot-assisted thyroidectomy
Eligibility Criteria
Inclusion
- Age between 20-65
- ASA class I and II
- Thyroid cancer patients who are scheduled for elective robot-assisted thyroidectomy
Exclusion
- Allergy to local anesthetics or contraindication to use of lidocaine
- Pregnancy
- Severe cardiovascular disease
- Renal failure
- Liver failure
- Neurologic and psychologic disease
- Chronic treatment with analgesics
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01907997
Start Date
July 1 2013
End Date
May 1 2015
Last Update
June 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei universiy college of medicine
Seoul, South Korea, 120-752